[Brachytherapy for localised prostate cancer].
Brachytherapy using I 125 permanent implants as monotherapy is a validated technique of treatment for localised prostate cancer with favorable prognostic factors, as external beam irradiation or surgery are. It necessitates a strict selection of the patients and a precise technique in a specialised unit. The narrow collaboration between radiation-oncologist, urologist en medical physicist is necessary along the successive steps of the selection, treatment, and follow-up of the treatment. The good carcinologic and functional 10 years results confirm the preliminary results. New indications of brachytherapy using other techniques and different combinations with external beam irradiation are investigated.
Peiffert
D
D
Département de Radiothérapie, Centre Alexis-Vautrin, 54500, Vandoeuvre-lès-Nancy Cedex, France. d.peiffert@nancy.fnclcc.fr
D001918:Brachytherapy / Q000009:adverse effects / Q000191:economics / Q000379:methods / Q000592:standards; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D008297:Male; D009367:Neoplasm Staging; D018579:Patient Selection; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D011787:Quality of Health Care; D011879:Radiotherapy Dosage; D013997:Time Factors; D016896:Treatment Outcome
D007457:Iodine Radioisotopes